ATE416174T1 - Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien - Google Patents

Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien

Info

Publication number
ATE416174T1
ATE416174T1 AT00985180T AT00985180T ATE416174T1 AT E416174 T1 ATE416174 T1 AT E416174T1 AT 00985180 T AT00985180 T AT 00985180T AT 00985180 T AT00985180 T AT 00985180T AT E416174 T1 ATE416174 T1 AT E416174T1
Authority
AT
Austria
Prior art keywords
homopiperidylbenzimidazole
relaxants
fundus
analogs
substituted
Prior art date
Application number
AT00985180T
Other languages
English (en)
Inventor
Frans Eduard Janssens
Jerome Emile Georges Guillemont
Francois Maria Sommen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE416174T1 publication Critical patent/ATE416174T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
AT00985180T 1999-12-21 2000-12-14 Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien ATE416174T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204441 1999-12-21

Publications (1)

Publication Number Publication Date
ATE416174T1 true ATE416174T1 (de) 2008-12-15

Family

ID=8241040

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985180T ATE416174T1 (de) 1999-12-21 2000-12-14 Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien

Country Status (33)

Country Link
US (1) US7304052B2 (de)
EP (1) EP1250337B1 (de)
JP (1) JP4852210B2 (de)
KR (1) KR100715351B1 (de)
CN (1) CN100343251C (de)
AT (1) ATE416174T1 (de)
AU (1) AU781144B2 (de)
BG (1) BG65784B1 (de)
BR (1) BRPI0016638B8 (de)
CA (1) CA2393158C (de)
CY (1) CY1108844T1 (de)
CZ (1) CZ299803B6 (de)
DE (1) DE60041001D1 (de)
DK (1) DK1250337T3 (de)
EA (1) EA005851B1 (de)
EE (1) EE05182B1 (de)
ES (1) ES2317856T3 (de)
HK (1) HK1053109B (de)
HR (1) HRP20020518B1 (de)
HU (1) HU229929B1 (de)
IL (2) IL150310A0 (de)
MX (1) MXPA02006346A (de)
MY (1) MY127758A (de)
NO (1) NO322362B1 (de)
NZ (1) NZ518816A (de)
PL (1) PL199678B1 (de)
PT (1) PT1250337E (de)
SI (1) SI1250337T1 (de)
SK (1) SK287113B6 (de)
TW (1) TWI225488B (de)
UA (1) UA73963C2 (de)
WO (1) WO2001046189A1 (de)
ZA (1) ZA200204983B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
US7160879B2 (en) 2002-01-10 2007-01-09 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
US7691860B2 (en) 2004-02-19 2010-04-06 Banyu Pharmaceutical Co., Ltd. Sulfonamide derivatives
ATE522530T1 (de) 2007-01-25 2011-09-15 Janssen Pharmaceutica Nv 2-piperazin-1-yl-3h-imidazoä4,5-bü- pyridinderivate
MX2012015292A (es) 2010-06-24 2013-05-30 Gilead Sciences Inc Pirazolo[1, 5]pirimidinas en la forma de agentes antivirales.
EP2643304A2 (de) * 2010-11-24 2013-10-02 Sequent Scientific Ltd. Verfahren zur herstellung von albendazol
JP2014159375A (ja) * 2011-06-15 2014-09-04 Takeda Chem Ind Ltd アゼパン化合物
ES2647486T3 (es) 2011-12-22 2017-12-21 Gilead Sciences, Inc. Pirazolo[1,5-a]pirimidinas como agentes antivirales
DK2838900T3 (da) 2012-04-17 2019-10-14 Gilead Sciences Inc Forbindelser og fremgangsmåder til antiviral behandling
WO2015091584A1 (en) * 2013-12-18 2015-06-25 F. Hoffmann-La Roche Ag Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060197C3 (de) 1970-12-08 1979-02-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 2-Aminobenzothiazol und dessen N-Alkylsubstitutionsprodukten
US4093726A (en) * 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
FR2528526A1 (fr) * 1982-06-09 1983-12-16 Sfr Sa Robinetterie Butee se fixant dans un alesage d'un dispositif
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE3634066A1 (de) * 1986-10-07 1988-04-21 Boehringer Mannheim Gmbh Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
JPH0260197A (ja) * 1988-08-26 1990-02-28 Nec Corp パッケージ構造
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
KR0144793B1 (ko) * 1992-07-08 1998-07-15 제임스 클리프튼 보올딩 돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
EP0711768B1 (de) * 1994-05-31 2002-02-13 Mitsui Chemicals, Inc. Benzimidazol-derivate
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues

Also Published As

Publication number Publication date
HU229929B1 (en) 2015-01-28
HRP20020518B1 (en) 2009-02-28
CA2393158C (en) 2010-10-19
UA73963C2 (uk) 2005-10-17
NO20022977L (no) 2002-08-08
CY1108844T1 (el) 2014-07-02
HK1053109B (zh) 2008-08-01
HUP0203847A2 (hu) 2003-03-28
US20030139393A1 (en) 2003-07-24
BR0016638A (pt) 2002-10-01
SK8542002A3 (en) 2003-07-01
EA005851B1 (ru) 2005-06-30
AU781144B2 (en) 2005-05-05
US7304052B2 (en) 2007-12-04
CZ20022055A3 (cs) 2003-06-18
PL199678B1 (pl) 2008-10-31
PT1250337E (pt) 2009-03-05
DK1250337T3 (da) 2009-03-30
AU2167301A (en) 2001-07-03
BR0016638B1 (pt) 2013-02-05
BRPI0016638B8 (pt) 2017-04-25
CA2393158A1 (en) 2001-06-28
KR100715351B1 (ko) 2007-05-08
SI1250337T1 (sl) 2009-04-30
WO2001046189A1 (en) 2001-06-28
EA200200700A1 (ru) 2003-06-26
CZ299803B6 (cs) 2008-12-03
ES2317856T3 (es) 2009-05-01
EE200200326A (et) 2003-10-15
MXPA02006346A (es) 2002-12-13
HK1053109A1 (en) 2003-10-10
HUP0203847A3 (en) 2004-07-28
BG65784B1 (bg) 2009-11-30
SK287113B6 (sk) 2009-12-07
NO20022977D0 (no) 2002-06-20
NO322362B1 (no) 2006-09-25
HRP20020518A2 (en) 2004-08-31
IL150310A0 (en) 2002-12-01
TWI225488B (en) 2004-12-21
CN1411460A (zh) 2003-04-16
EP1250337A1 (de) 2002-10-23
IL150310A (en) 2008-07-08
CN100343251C (zh) 2007-10-17
BG106749A (en) 2003-01-31
DE60041001D1 (de) 2009-01-15
JP4852210B2 (ja) 2012-01-11
JP2003518118A (ja) 2003-06-03
KR20020062643A (ko) 2002-07-26
EE05182B1 (et) 2009-06-15
NZ518816A (en) 2003-01-31
ZA200204983B (en) 2003-09-22
EP1250337B1 (de) 2008-12-03
PL355442A1 (en) 2004-04-19
MY127758A (en) 2006-12-29

Similar Documents

Publication Publication Date Title
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
GB0127903D0 (en) Improvements relating to organic compounds
BG66085B1 (bg) Фенилаланинови производни
DE60214990D1 (de) Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
ES2188666T3 (es) Analogos de la distamicina utilies como agentes antitumorales o antivirales.
SE0201635D0 (sv) Novel compounds
NO20062950L (no) 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
EA199800752A1 (ru) Пентафторбензолсульфонамиды и их аналоги
MA27549A1 (fr) N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
BR0313969A (pt) Inibidores de oxitocina
SE9901077D0 (sv) Novel use
ATE416174T1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
CO5680420A2 (es) Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
BRPI0416678A (pt) pirazolpirimidinas
EA200100297A1 (ru) Моногидрат гидробромида элетриптана
TR200102501T2 (tr) Antiviral nükleozid analoglar.
SE9604582D0 (sv) Novel compounds
DE69524064D1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
TNSN05276A1 (fr) 5,7-diaminopyrazolo[4,3-d] pyrimidines utiles dans le traitement de l'hypertension
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250337

Country of ref document: EP